|

HOME-AHCL: Home-Based Implementation of an Advanced Hybrid Closed-Loop System With Telemonitoring in Type 1 Diabetes

RECRUITINGSponsored by Air Liquide Healthcare Spain
Actively Recruiting
SponsorAir Liquide Healthcare Spain
Started2026-04-22
Est. completion2028-05
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The goal of this prospective, single-arm observational study is to characterise a home-based setup and telemonitoring care model for an advanced hybrid closed-loop insulin pump system (Tandem Control-IQ) in adults with type 1 diabetes. The study characterises safety, glycaemic outcomes, direct healthcare costs, and impact on quality of life and user experience over 12 months. The main research questions are: * What is the safety profile of initiating the insulin pump system at home, measured by the percentage of sensor time spent below 54 mg/dL at 12 months? * What longitudinal changes in glycaemic metrics (such as Time in Range) are observed within the cohort following home-based initiation? * What changes in quality of life, technology satisfaction and healthcare experience are observed during follow-up? * What are the direct healthcare costs and resource utilization patterns associated with this care pathway from a public healthcare system perspective? Participants will: * Complete an online technical training course prior to system activation. * Receive a home visit from a specialised nurse to configure and start the insulin pump system. * Have their continuous glucose monitoring data reviewed remotely every 14 days by the nursing team to manage automated clinical alerts. * Attend scheduled clinical follow-up assessments at 1, 3, 6, and 12 months. * Complete questionnaires assessing quality of life, patient experience, and device satisfaction.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Diagnosis of type 1 diabetes.
* Aged 18 years or older.
* Candidate to initiate an Advanced Hybrid Closed-Loop (AHCL) system based on standard clinical criteria.
* Access to the internet and/or a compatible smartphone to connect to the system.
* Willingness to participate in the study and sign the informed consent form.

Exclusion Criteria:

* Currently participating in another diabetes-related clinical trial.
* Pregnant or planning to become pregnant during the study.
* Inability to use the system autonomously (e.g., severe cognitive impairment or severe psychiatric disorders without support).
* Medical contraindication for the use of insulin pumps or continuous glucose monitors (CGM).

Conditions2

DiabetesDiabetes Mellitus, Type 1

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.